We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

109 hedge funds and large institutions have $861M invested in Enfusion, Inc. in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,317% more call options, than puts

Call options by funds: $445K | Put options by funds: $6K

145% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 22

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

11% more capital invested

Capital invested by funds: $774M → $861M (+$87.9M)

8% more funds holding

Funds holding: 101109 (+8)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
109
Holders Change
+8
Holders Change %
+7.92%
% of All Funds
1.57%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
54
Reduced
22
Closed
9
Calls
$445K
Puts
$6K
Net Calls
+$439K
Net Calls Change
+$36K
Name Holding Trade Value Shares
Change
Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$181K -$4.43K -513 -3%
VOYA Investment Management
77
VOYA Investment Management
Georgia
$166K +$992 +115 +0.7%
Wells Fargo
78
Wells Fargo
California
$165K -$1.66K -192 -1%
PP
79
Paloma Partners
Connecticut
$157K +$143K +16,544 New
T. Rowe Price Associates
80
T. Rowe Price Associates
Maryland
$157K +$9.07K +1,051 +7%
Amundi
81
Amundi
France
$146K
Squarepoint
82
Squarepoint
New York
$143K -$561K -65,043 -81%
AQR Capital Management
83
AQR Capital Management
Connecticut
$124K -$67K -7,767 -37%
Invesco
84
Invesco
Georgia
$115K +$2.29K +265 +2%
Belvedere Trading
85
Belvedere Trading
Illinois
$114K +$104K +12,041 New
ASRS
86
Arizona State Retirement System
Arizona
$113K +$15.9K +1,845 +18%
HCA
87
Harbor Capital Advisors
Illinois
$113K +$11.3K +1,315 +12%
TRCT
88
Tower Research Capital (TRC)
New York
$79.1K +$2.54K +294 +4%
Zurich Cantonal Bank
89
Zurich Cantonal Bank
Switzerland
$63.9K
Royal Bank of Canada
90
Royal Bank of Canada
Ontario, Canada
$55K -$81.1K -9,394 -62%
AIP
91
Ameritas Investment Partners
Nebraska
$47.1K +$10.2K +1,177 +31%
Acadian Asset Management
92
Acadian Asset Management
Massachusetts
$38K +$35.4K +4,102 New
SSG
93
Summit Securities Group
New York
$30K +$18.7K +2,165 +217%
Osaic Holdings
94
Osaic Holdings
Arizona
$26.6K +$14.8K +1,716 +158%
AB
95
Amalgamated Bank
New York
$13K
Group One Trading
96
Group One Trading
Illinois
$8.29K +$7.54K +874 New
ACM
97
Aquatic Capital Management
Illinois
$7.11K +$6.46K +749 New
Fidelity Investments
98
Fidelity Investments
Massachusetts
$6.07K -$923 -107 -14%
GI
99
GAMMA Investing
California
$4.47K +$1.1K +127 +37%
Nisa Investment Advisors
100
Nisa Investment Advisors
Missouri
$2.48K +$1.68K +195 +295%

ENFN Hedge Fund Activity: Q3 2024 in Review

109 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q3 2024, worth a combined $861M — up 11% from $774M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ENFN positions and 9 closed out — a net gain of 10 holders — while 54 added to existing stakes and 22 trimmed.

The largest buyer was Lead Edge Capital Management, adding an estimated $5.82M. The largest seller was Brown Capital Management, cutting an estimated $11.8M.

  • 109 institutional investors held Enfusion, Inc. (ENFN) as of Q3 2024, up from 101 in Q2 2024.
  • Funds reported $861M of Enfusion, Inc. stock for Q3 2024, up 11% quarter-over-quarter.
  • 19 funds opened new Enfusion, Inc. positions in Q3 2024 and 9 closed out, a net change of +10 holders.
  • The largest Enfusion, Inc. buyer in Q3 2024 was Lead Edge Capital Management, an estimated $5.82M added.
  • The largest Enfusion, Inc. seller in Q3 2024 was Brown Capital Management, an estimated $11.8M sold.

Based on aggregated 13F filings for Q3 2024.